NurExone Biologic Inc. has successfully doubled its exosome production by operating two bioreactors in parallel without increasing manufacturing time or compromising quality. This achievement supports the company's modular manufacturing strategy, allowing scalable production by adding standardized units rather than larger bioreactors. The consistent quality and yield enhance NurExone's ability to meet future demand and strengthen its position in the regenerative therapy market. The company plans to expand production capabilities further to support both its therapeutic pipeline and commercial opportunities for naïve exosomes.
NurExone Biologic Inc.'s scalable exosome production is the subject of this update. For readers following the health sector, here is Pluang's market snapshot as of Oct 22, 2026 19:13 WIB: out of 150 priced US health stocks, 63 rose and 79 fell. Notable movers include TWST at USD 142.45 with a 7% Sell / 93% Buy Pluang order activity, DGX at USD 229.99, and SMMT at USD 15.32.
Flutter Entertainment, a leading online sports betting and iGaming operator, will release its third quarter 2026 update on November 4 before the US market opens. The company will host a conference call at 8:30 a.m. ET the same day to discuss the resu...
iPower Inc. declared a 1-for-12 reverse stock split effective October 26, 2026, combining every 12 shares into one to increase the stock price. This move aims to keep iPower's shares compliant with Nasdaq's minimum bid price requirements. Post-split,...
U.S. Global Investors has listed its actively managed U.S. Global Technology and Aerospace & Defense ETF (WAR) on Peru's Lima Stock Exchange, marking the first availability of this ETF outside the U.S. This move gives Peruvian investors access to a f...
Alignment Health Plan will launch a new Medicare Advantage plan in Pima County starting January 1, 2027, increasing access to affordable, coordinated healthcare for nearly 1.1 million Medicare beneficiaries across Maricopa, Pima, and Santa Cruz count...
The global Urban Air Mobility (UAM) market is projected to grow from $2.16 billion in 2026 to $16.27 billion by 2035, at a CAGR of 20.9%. This growth is fueled by rising urbanization, traffic congestion, and advances in electric vertical takeoff and ...
